Skip to main content
Clinical Trials/NCT03557736
NCT03557736CompletedNot Applicable

Effects of a 12-Week Home-Based High-Intensity Interval Training Programme in Obese Individuals With Elevated Cardiovascular Disease Risk: A Pilot Study

Liverpool John Moores University2 sites in 1 country32 target enrollmentStarted: March 9, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
32
Locations
2
Primary Endpoint
change in aerobic fitness

Study Overview

Brief Summary

This study aims to investigate the efficacy of a novel home-based high-intensity interval training (Home-HIT) intervention in obese individuals, with elevated cardiovascular disease (CVD) risk. It was hypothesised that Home-HIT would 1) have high adherence to the prescribed exercise intensity (compliance), 2) improve markers of CVD risk, and 3) lead to favourable skeletal muscle adaptations.

Detailed Description

The applicability of current high intensity interval training (HIT) protocols to the sedentary obese population has been disputed by public health experts. Existing HIT interventions have been successful only under optimal conditions with high levels of supervision and specialised equipment, creating further barriers to exercise in those most in need. We aimed to eliminate many of these barriers by modifying existing HIT protocols to create a new home-based HIT (Home-HIT) intervention tailored to individuals with low fitness and mobility. It was hypothesised that Home-HIT would 1) have high adherence to the prescribed exercise intensity (compliance) and 2) improve markers of cardiovascular disease (CVD) risk. 32 Obese adults with at least 3 additional CVD risk factors (age 36±2 y; BMI 34.3±0.8 kg∙m-2; VO2peak 24.6±1.0 ml∙kg∙min-1), completed one of three 12-week training programmes 3x/week: Home-HIT (n=9); Laboratory-based supervised HIT (Lab-HIT; n=10) or home-based moderate intensity continuous training (Home-MICT; n=13). Adherence and compliance were monitored online in almost "real time" using a heart rate (HR) monitor and mobile app. The Home-HIT group completed 4 progressing to 8 1min intervals interspersed with 1min of rest in an unsupervised place of their choosing. The intervals were composed of simple bodyweight exercises that required no equipment. Changes in VO2peak, insulin sensitivity, body composition, flow-mediated dilation (FMD) and aortic pulse wave velocity (PWV) were assessed. Muscle biopsies were taken to assess changes in capillarisation, mitochondrial density, intramuscular triglyceride (IMTG) content and eNOS and GLUT4 protein expression using quantitative immunofluorescence microscopy.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • obesity (BMI >30 kg/m2)
  • age 18-55

Exclusion Criteria

  • diagnosed CVD and other contraindications to participate in an exercise intervention
  • BMI <30 kg/m2

Arms & Interventions

Home-HIT

Experimental

Home-based high-intensity interval training: participants performed 12 weeks of simple body weight exercises in a place of their own choosing 3x/week

Intervention: Training mode (Behavioral)

Home-MICT

Experimental

Home-based moderate-intensity interval training: participants performed 12 weeks of continuous exercise (running, swimming or cycling) in a place of their own choosing 3x/week

Intervention: Training mode (Behavioral)

Lab-HIT

Experimental

Laboratory-based high-intensity interval training: participants performed supervised cycle exercise under laboratory conditions 3x/week for 12 weeks

Intervention: Training mode (Behavioral)

Outcomes

Primary Outcomes

change in aerobic fitness

Time Frame: change in baseline aerobic fitness at 12 weeks

change in maximal aerobic capacity following the training

Adherence and compliance to the exercise training intervention

Time Frame: adherance and compliance to the training over the 12 weeks

Session completion rate (adherence) and ability to meet target heart rates (compliance)

Secondary Outcomes

  • change in body fat percentage(chage in baseline body fat percentage at 12 weeks)
  • change in baseline FMD(change in baseline FMD at 12 weeks)
  • change in vascular stiffness(change in baseline vascular stiffness at 12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sam Shepherd

Dr Sam Shepherd

Liverpool John Moores University

Study Sites (2)

Loading locations...

Similar Trials